Studies in bullous diseases. Immunofluorescent serologic tests.
D000324:Adrenocorticotropic Hormone / Q000627:therapeutic use; D000328:Adult; D000974:Antibodies, Antinuclear; D001323:Autoantibodies; D001485:Basement Membrane / Q000276:immunology; D001768:Blister / Q000276:immunology*; D002648:Child; D002675:Child, Preschool; D003874:Dermatitis Herpetiformis / Q000276:immunology; D003937:Diagnosis, Differential; D004892:Erythema Multiforme / Q000276:immunology; D004947:Esophagus / Q000276:immunology; D005260:Female; D005455:Fluorescent Antibody Technique; D006801:Humans; D008297:Male; D008722:Methods; D008775:Methylprednisolone / Q000627:therapeutic use; D008875:Middle Aged; D009157:Myasthenia Gravis / Q000150:complications; D010392:Pemphigus / Q000188:drug therapy / Q000209:etiology / Q000276:immunology*; D011241:Prednisone / Q000627:therapeutic use; D011379:Prognosis; D012871:Skin Diseases / Q000175:diagnosis / Q000188:drug therapy / Q000276:immunology*
D000974:Antibodies, Antinuclear; D001323:Autoantibodies; D000324:Adrenocorticotropic Hormone; D011241:Prednisone; D008775:Methylprednisolone